Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Early diagnosis and a multidisciplinary approach are crucial for managing Frontal Fibrosing Alopecia.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Trichoscopy can reveal specific hair and scalp changes in linear morphea.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

Frontal fibrosing alopecia is linked to thyroid disease, lupus, vitiligo, and heart disease.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

Current methods for grading hair loss from cancer treatment are not accurate enough and need improvement.

APCs may improve hair density in cicatricial alopecia but effects may not last long.

Androgenetic alopecia is common hair loss due to genetics and hormones, manageable with early treatment.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Low-level laser therapy reduces symptoms and inflammation in frontal fibrosing alopecia.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Medical treatments can help manage frontal fibrosing alopecia, but hair transplantation should be done cautiously and only if the disease is inactive.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The first Japanese family with Marie Unna hereditary hypotrichosis showed hair condition improvement in a child and highlighted the risk of misdiagnosis.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.